Systemic Safety of Prolonged Monthly Anti-Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema: A Systematic Review and Meta-analysis.

Avery, Robert L; Gordon, Gabriel M

Avery, Robert L; Gordon, Gabriel M.

Affiliation

Avery RL; California Retina Consultants and Research Foundation, Santa Barbara.
Gordon GM; California Retina Consultants and Research Foundation, Santa Barbara.

JAMA Ophthalmol ; 134(1): 21-9, 2016 Jan.

Article in En | MEDLINE | ID: mdl-26513684

Subject(s)

Angiogenesis Inhibitors/administration & dosage; Angiogenesis Inhibitors/adverse effects; Diabetic Retinopathy/drug therapy; Macular Edema/drug therapy; Vascular Endothelial Growth Factor A/antagonists & inhibitors; Cause of Death; Databases, Factual; Humans; Intravitreal Injections; Ranibizumab/administration & dosage; Ranibizumab/adverse effects; Receptors, Vascular Endothelial Growth Factor/administration & dosage; Receptors, Vascular Endothelial Growth Factor/adverse effects; Recombinant Fusion Proteins/administration & dosage; Recombinant Fusion Proteins/adverse effects; Risk Factors; Stroke/chemically induced

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Macular Edema / Angiogenesis Inhibitors / Vascular Endothelial Growth Factor A / Diabetic Retinopathy Type of study: Clinical_trials / Etiology_studies / Prognostic_studies / Systematic_reviews Limits: Humans Language: En Journal: JAMA Ophthalmol Year: 2016 Type: Article

Fulltext

XML

PubMed Links

Search on Google